Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Lung Cancer (Amsterdam, Netherlands)|May 17, 2011
Continuous EGFR-TKI administration following radiotherapy for non-small cell lung cancer patients with isolated CNS failureTakehito Shukuya, Toshiaki Takahashi, Tateaki Naito, et al.
Anticancer Research|January 31, 2012
Comparison of vinorelbine plus cisplatin and S-1 plus cisplatin in concurrent chemoradiotherapeutic regimens for unresectable stage III non-small cell lung cancerTakehito Shukuya, Toshiaki Takahashi, Hideyuki Harada, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 20, 2012
Prognostic impact of circulating tumor cells in patients with small cell lung cancerTateaki Naito, Fumihiro Tanaka, Akira Ono, et al.
Lung Cancer (Amsterdam, Netherlands)|February 4, 2012
Correlations between serial pro-gastrin-releasing peptide and neuron-specific enolase levels, and the radiological response to treatment and survival of patients with small-cell lung cancerAkira Ono, Tateaki Naito, Ichiro Ito, et al.
Molecular Cancer Therapeutics|August 7, 2010
Phase I safety, pharmacokinetic, and biomarker study of BIBF 1120, an oral triple tyrosine kinase inhibitor in patients with advanced solid tumorsIsamu Okamoto, Hiroyasu Kaneda, Taroh Satoh, et al.
Lung Cancer (Amsterdam, Netherlands)|July 22, 2010
Biologic correlates of ¹⁸F-FDG uptake on PET in pulmonary pleomorphic carcinomaKyoichi Kaira, Masahiro Endo, Masato Abe, et al.
Oncology Reports|September 3, 2010
CD98 expression is associated with the grade of malignancy in thymic epithelial tumorsKyoichi Kaira, Toshiaki Takahashi, Masato Abe, et al.
Investigational New Drugs|May 25, 2012
A phase I study of S-1 with concurrent radiotherapy in elderly patients with locally advanced non-small cell lung cancerYoshikazu Hasegawa, Isamu Okamoto, Ken Takezawa, et al.
Oncology Letters|August 1, 2012
Differential efficacy of docetaxel according to non-small cell lung cancer histology and the therapeutic effect of epidermal growth factor receptor tyrosine kinase inhibitorsSatoru Miura, Haruyasu Murakami, Akihiro Tamiya, et al.
American Journal of Clinical Oncology|December 6, 2012
The impact of clinical outcomes according to EGFR mutation status in patients with locally advanced lung adenocarcinoma who recieved concurrent chemoradiotherapyHiroaki Akamatsu, Kyoichi Kaira, Haruyasu Murakami, et al.
Pageof 7